Quarterly Financials | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 573 | 635 | 647 | 648 | 684 |
Expenses | 405 | 494 | 470 | 454 | 476 |
EBITDA  | 168 | 140 | 177 | 194 | 208 |
Operating Profit % | 29 % | 20 % | 27 % | 29 % | 28 % |
Depreciation | 19 | 27 | 28 | 28 | 28 |
Interest | 26 | 32 | 26 | 22 | 21 |
Profit Before Tax  | 124 | 81 | 122 | 144 | 160 |
Tax | 22 | 17 | 27 | 31 | 31 |
Net Profit | 102 | 64 | 96 | 113 | 130 |
EPS in ₹ | 6.14 | 3.76 | 5.64 | 6.80 | 7.80 |
Above figures are in Rs. Crores Balance Sheet | 2021 | 2022 | 2023 | 2024 |
Total Assets  | 586 | 788 | 988 | 3,028 |
Fixed Assets | 87 | 76 | 59 | 1,833 |
Current Assets | 345 | 461 | 698 | 898 |
Capital Work in Progress | 0 | 0 | 0 | 3 |
Investments | 14 | 16 | 32 | 195 |
Other Assets | 485 | 696 | 898 | 997 |
Total Liabilities  | 586 | 788 | 988 | 3,028 |
Current Liabilities | 59 | 83 | 115 | 790 |
Non Current Liabilities | 70 | 58 | 45 | 1,080 |
Total Equity  | 457 | 647 | 829 | 1,158 |
Reserve & Surplus | 448 | 630 | 812 | 1,140 |
Share Capital | 8 | 17 | 17 | 17 |
Above figures are in Rs. Crores Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 |
Net Cash Flow | 43 | -28 | 92 | -22 | -147 |
Investing Activities | -79 | -167 | -82 | -158 | -1,137 |
Operating Activities | 163 | 175 | 233 | 288 | 210 |
Financing Activities | -41 | -37 | -59 | -152 | 780 |
Above figures are in Rs. Crores % Holding | Aug 2024 | Dec 2024 | Mar 2025 |
Promoter | 69.73 % | 63.72 % | 63.72 % |
FIIs | 0.00 % | 5.48 % | 5.39 % |
DIIs | 0.00 % | 4.45 % | 4.03 % |
Government | 0.00 % | 0.00 % | 0.00 % |
Public / Retail | 0.00 % | 10.25 % | 10.93 % |
Others | 30.27 % | 16.10 % | 15.93 % |
No of Share Holders | 110 | 109 | 57,714 |
Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10 | 0.00 |
Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.65 | 0.00 |
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
2 days ago Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)
2 days ago Intimation Of Change In E-Mail And Website Address Of Registrar And Share Transfer Agent Of The Company
2 days ago Announcement under Regulation 30 (LODR)-Acquisition
3 days ago Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Apr 10, 2025 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Apr 02, 2025 Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Apr 02, 2025 Closure of Trading Window
Mar 27, 2025 Press Release - IKS Health Wins Additional Top Honors In 2025 Black Book Surveys In Clinical Documentation And Medical Coding
Mar 19, 2025 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Mar 12, 2025 Press Release - IKS Health Wins Top Honors In 2025 Black Book Survey In New AI-Driven RCM Category.
Mar 11, 2025 Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Order From Reserve Bank Of India Central Office Mumbai.
Mar 05, 2025 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 21, 2025 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 15, 2025 Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Feb 12, 2025 Newspaper Advertisement Confirming Dispatch Of Postal Ballot Notice
Feb 09, 2025 Newspaper Publication Of Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024.
Feb 07, 2025 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Feb 07, 2025 Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Feb 06, 2025 Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 05, 2025 Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 05, 2025 Integrated Filing (Financial)
Feb 05, 2025 Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024.
Feb 05, 2025 Board Meeting Outcome for Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) - Outcome Of The Board Meeting Held On Februar
Feb 05, 2025 Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Order From Reserve Bank Of India Central Office Mumbai.
Jan 29, 2025 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 22, 2025 Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Order From Reserve Bank Of India Central Office Mumbai.
Jan 20, 2025 Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)
Jan 16, 2025 Certificate Under Regulation 74(5) Of Securities And Exchange Board Of India (Depositories And Participants) Regulations 2018 For The Quarter Ended December 31 2024.
Jan 14, 2025 Intimation Of Change In Name Of Registrar And Share Transfer Agent Of The Company.
Jan 02, 2025 Closure of Trading Window
Dec 27, 2024 RSI(14)

Neutral
47.93
ATR(14)

Less Volatile
73.51
STOCH(9,6)

Neutral
78.51
STOCH RSI(14)

Overbought
86.18
MACD(12,26)

Bullish
19.88
ADX(14)

Weak Trend
22.23
UO(9)

Bearish
53.31
ROC(12)

Uptrend And Accelerating
3.51
WillR(14)

Neutral
-20.14